ArticleNature2018
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.
Joseph A Fraietta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
544 papers cite itlatest 60 shown
this paperpooled ittrialcites it